Hormonal
Plasma ghrelin levels increase with fasting and decrease after meals, with levels being higher after diet-induced weight loss compared to gastric bypass surgery.
When you lose weight through dieting, your body naturally increases ghrelin levels, making you hungrier. This is a biological response, not a personal failure. Gastric bypass surgery, by contrast, suppresses ghrelin levels, which may contribute to its effectiveness. Managing expectations about increased hunger during weight loss can help in adhering to long-term strategies.
Rat serum ghrelin concentrations were increased by fasting and were reduced by refeeding or oral glucose administration... They found an increase in the plasma ghrelin level with diet-induced weight loss. Gastric bypass was associated with markedly suppressed ghrelin levels, possibly contributing to the weight-reducing effect of the procedure.
Why this rating
Supported by multiple studies (Tschop, Cummings) cited in the review.
Source
Ghrelin: a hormone regulating food intake and energy homeostasis
Mercedes Gil‐Campos et al. · British Journal Of Nutrition · 2006
DOI 10.1079/bjn20061787
More from this paper
- Ghrelin is an orexigenic hormone that stimulates food intake and reduces energy expenditure by activating NPY/AgRP neurons in the hypothalamus, acting in opposition to leptin.Strong
- Obestatin, a peptide derived from the same gene as ghrelin, suppresses food intake and decreases body weight gain, acting as an anorexigenic counter-regulator to ghrelin.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →